NCT00441415View on ClinicalTrials.gov

Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

272

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Acne Vulgaris
Interventions
DRUG

Adapalene BPO

Trial Locations (4)

14609

Elisabeth ARTHUR, Rochester

55432

Steven E. KEMPERS, Fridley

87106

Dr Alicia BUCKO, Albuquerque

90404

Paul YAMAUCHI, Santa Monica

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT00441415 - Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter